Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 7—July 2007

Antimicrobial Drugs and Community-acquired Methicillin-Resistant Staphylococcus aureus, United Kingdom

Verena Schneider-Lindner*†, J. A. Delaney*†, Sandra Dial†‡, Andre Dascal‡, and Samy Suissa*†Comments to Author 
Author affiliations: *McGill University Health Center, Montreal, Quebec, Canada; †Royal Victoria Hospital, Montreal, Quebec, Canada; ‡Sir Mortimer B. Davis–Jewish General Hospital, Montreal, Quebec, Canada;

Main Article

Table 1

Characteristics of patients with (case-patients) and without (control-patients) a diagnosis of community-acquired methicillin-resistant Staphylococcus aureus*

Lifestyle factors
Smoking 718 (36.2) 6,365 32.2) 1.21 1.06 0.95–1.17
Obesity 323 (16.3) 2,253 (11.4) 1.54 1.27 1.10–1.47‡

*Data from the General Practice Research Database, United Kingdom, 2000–2004. OR, odds ratio; CI, confidence interval; MI, myocardial infarction; COPD, chronic obstructive pulmonary disease.
†Adjusted for all other variables in the table and exposure to antimicrobial drugs in the 30–365 days period before the index date.

Main Article

Page created: June 21, 2010
Page updated: June 21, 2010
Page reviewed: June 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.